Trial · NCT02099747
hATG+CsA vs hATG+CsA+Eltrombopag for SAA
NCT02099747, Phase 3, Completed, European Society for Blood and Marrow Transplantation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. hATG+CsA vs hATG+CsA+Eltrombopag for SAA. Trials, record NCT02099747. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02099747
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- hATG+CsA vs hATG+CsA+Eltrombopag for SAA
- NCT number
- NCT02099747
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 202 participants, actual
- Lead sponsor
- European Society for Blood and Marrow Transplantation
- Conditions
- Severe Aplastic Anemia
- Interventions
- hATG, CsA, Eltrombopag
- First posted
- 2014-03-31
- Last updated
- 2026-04-24
- Other registries' IDs
- eudract:2014-000363-40
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | CR rate | 3 months | The primary objective of this trial is to investigate whether Eltrombopag added to standard immunosuppressive treatment increases the rate of early (at three months) complete response in untreated AA patient. |
| Secondary | Time to best heamatological response | 2 year | |
| Secondary | Heamatological Response at 6, 12, 18 and 24 months | 2 year | |
| Secondary | Cumulative incidence of response | 2 year | |
| Secondary | Overall survival | 2 year | |
| Secondary | Event-free survival | 2 year | |
| Secondary | Cumulative incidence of relapse rate | 2 year | |
| Secondary | Cumulative incidences of clonal evolution | 2 year | |
| Secondary | Cumulative incidence of PNH population occurrence and clinical hemolytic PNH occurrence | 2 year | |
| Secondary | Cumulative incidence of discontinuation of immunosuppressive therapy | 2 year |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02099747
GET https://conductscience.org/api/trials/v1/NCT02099747/registered